Zi Shen Decoction Inhibits Growth and Metastasis of Lung Cancer via Regulating the AKT/GSK-3β/β-Catenin Pathway

Figure 1

The network pharmacology analysis of ZSD. (a) The flowchart of the network pharmacology. (b) Compound-target network: the red diamond nodes represent compounds of ZSD. The blue circle nodes represent corresponding targets. (c) GO enrichment analysis of the candidate targets of ZSD. (d) KEGG pathway enrichment analysis of candidate targets of ZSD. (e) Molecular docking process of 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-(3-methylbut-2-enyl) chromone-4-one with AKT1. (f) Docking process of quercetin with AKT1. (g) Docking process of quercetin with EGFR. (h) Docking process of quercetin with ALK.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)